COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 174 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $339,339 | -53.0% | 14,145 | -65.3% | 0.02% | -44.7% |
| Q2 2022 | $722,000 | -36.4% | 40,738 | -26.9% | 0.04% | -36.7% |
| Q1 2022 | $1,135,000 | +15.0% | 55,739 | +5.5% | 0.06% | 0.0% |
| Q4 2021 | $987,000 | +33.0% | 52,815 | +40.5% | 0.06% | +42.9% |
| Q3 2021 | $742,000 | -30.0% | 37,589 | -16.1% | 0.04% | -26.3% |
| Q2 2021 | $1,060,000 | -4.2% | 44,827 | -4.0% | 0.06% | -9.5% |
| Q1 2021 | $1,107,000 | +4.2% | 46,702 | -11.9% | 0.06% | -18.2% |
| Q4 2020 | $1,062,000 | -62.8% | 53,020 | -61.3% | 0.08% | -17.2% |
| Q3 2020 | $2,853,000 | -7.8% | 137,049 | -22.5% | 0.09% | +16.2% |
| Q2 2020 | $3,095,000 | +54.9% | 176,854 | +44.5% | 0.08% | +50.9% |
| Q1 2020 | $1,998,000 | -32.0% | 122,381 | -14.3% | 0.05% | +29.3% |
| Q4 2019 | $2,939,000 | +798.8% | 142,799 | +400.7% | 0.04% | +925.0% |
| Q3 2019 | $327,000 | – | 28,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |